SRC and pulmonary fibrosis: Using an in vivo murine model of bleomycin‐induced VILI, we demonstrated that nintedanib attenuated high tidal volume MV‐induced lung inflammation‐associated EMT, pulmonary fibrosis and epithelial apoptosis through the inhibition of Src signalling pathway and TGF‐β1 production.